Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly

Heart Rhythm

Volumn 5, Issue 5, 2008, Pages 646-653

  Groeneveld, Peter W ^a,b,c   Farmer, Steven A ^b   Suh, Janice J ^b   Matta, Mary Anne ^b   Yang, Feifei ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cost benefit analysis; Death; Defibrillation; Prognosis; sudden; Survival

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; ELDERLY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SUDDEN DEATH; SURVIVAL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH CARE COSTS; HEART FAILURE; HUMANS; MALE; PRIMARY PREVENTION; TREATMENT OUTCOME;

EID: 42649092531     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.01.038     Document Type: Article

References (32)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Phurrough G., Salive M., Baldwin J., et al. Center for Medicare and Medicaid Services CAG #00157R3: coverage decision memorandum for implantable cardioverter defibrillators (2005)
4. Mushlin A.I., Hall W.J., Zwanziger J., et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 97 (1998) 2129-2135
5. Groeneveld P.W., Matta M.A., Suh J.J., et al. Costs and quality-of-life effects of implantable cardioverter-defibrillators. Am J Cardiol 98 (2006) 1409-1415
6. Al-Khatib S.M., Anstrom K.J., Eisenstein E.L., et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med 142 (2005) 593-600
7. Sanders G.D., Hlatky M.A., and Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353 (2005) 1471-1480
8. Parker A.B., Yusuf S., and Naylor C.D. The relevance of subgroup-specific treatment effects: the Studies of Left Ventricular Dysfunction (SOLVD) revisited. Am Heart J 144 (2002) 941-947
9. Rosenbaum P.R., and Rubin D.B. The bias due to incomplete matching. Biometrics 41 (1985) 103-116
10. Rosenbaum P.R. Optimal matching for observational studies. J Am Stat Assoc 84 (1989) 1024-1032
11. Rosenbaum P.R., and Rubin D.B. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 39 (1985) 33-38
12. Taira D.A., Seto T.B., Siegrist R., et al. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J 145 (2003) 452-458
13. Rosenbaum P.R. Observational Studies. 2d ed. (2002), Springer, New York
14. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
15. Foster E.M. Propensity score matching: an illustrative analysis of dose response. Med Care 41 (2003) 1183-1192
16. Austin P.C., and Mamdani M.M. A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 25 (2006) 2084-2106
17. Glynn R.J., Schneeweiss S., and Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 98 (2006) 253-259
18. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
19. Goldberger Z., and Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 295 (2006) 809-818
20. Reynolds M.R., Cohen D.J., Kugelmass A.D., et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2493-2497
21. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
22. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
23. McClellan M.B., and Tunis S.R. Medicare coverage of ICDs. N Engl J Med 352 (2005) 222-224
24. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
25. Mark D.B., Nelson C.L., Anstrom K.J., et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 114 (2006) 135-142
26. Weiss J.P., Saynina O., McDonald K.M., et al. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries. Am J Med 112 (2002) 519-527
27. Sturmer T., Joshi M., Glynn R.J., et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 59 (2006) 437-447
28. Hak E., Verheij T.J., Grobbee D.E., et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Commun H 56 (2002) 951-955
29. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Circulation 114 (2006) e385-e484
30. Schneider E.C., Leape L.L., Weissman J.S., et al. Racial differences in cardiac revascularization rates: does "overuse" explain higher rates among white patients?. Ann Intern Med 135 (2001) 328-337
31. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol 45 (2005) 72-78
32. Werner R.M., Asch D.A., and Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation 111 (2005) 1257-1263